Lenarium Lenalidomide Capsules 25 mg is a prescription oral oncology medicine identified as containing Lenalidomide 25 mg per capsule.

Lenalidomide is an immunomodulatory imide drug (IMiD) used in selected hematology-oncology treatment settings, particularly multiple myeloma.

It acts through cereblon-dependent mechanisms that alter cellular protein regulation, influence immune activity and contribute to antineoplastic effects.

Lenalidomide is used in selected combination regimens for multiple myeloma and in certain other hematological malignancies.

Lenalidomide can also cause severe myelosuppression and venous or arterial thromboembolic events.

The stated 25 mg capsule strength does not establish the appropriate dose for every patient. Dosing depends on the indication, kidney function, treatment schedule and toxicity.

The exact manufacturer, pack size, capsule composition, storage conditions, approved indications and controlled-distribution requirements of Lenarium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Lenarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features